Even as the market has remained volatile over the past few months due to rising inflation and a resurgence of COVID-19 cases, some companies have remained relatively stable based on their fundamental strength. Thermo Fisher (TMO), Vertex Pharmaceuticals (NASDAQ:VRTX), and Turkcell Iletisim (NYSE:TKC) are examples of this. So, we think they are well-positioned to dodge market volatility and as such should be a good addition to one’s portfolio now. Read on.Last week, the Senate’s approval of a compromise bill helped avoid a U.S. debt default. Also, according to a Factset report, more S&P 500 companies have issued positive EPS guidance for the third quarter. However, the market remains volatile because ongoing supply chain disruptions and rising oil prices are adding fuel to an inflationary environment.
Furthermore, the spread of the COVID-19 cases continues to concern investors regarding the pace of the global economic recovery. According to a Bankrate survey, most top experts believe that a stock market correction is likely within the next year.
Amid current volatility, Thermo Fisher Scientific Inc. (NYSE:TMO), Vertex Pharmaceuticals Incorporated (VRTX), and Turkcell Iletisim Hizmetleri A.S. (TKC) could be good additions to one’s portfolio. Their less-than-one beta and solid growth attributes could help them dodge the volatility.